Navigation Links
Pharmasset Selected to Join the NASDAQ Biotechnology Index
Date:5/12/2008

- Index Changes Scheduled to Take Effect with the Market Open on Monday,

May 19th -

PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, is pleased to announce that it has been selected to join the NASDAQ Biotechnology Index effective with the market open on May 19, 2008.

The NASDAQ Biotechnology Index is the basis for the iShares NASDAQ Biotechnology Index(sm) Fund (AMEX: IBB), which seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index. In addition, options based on the NASDAQ Biotechnology Index and the iShares NASDAQ Biotechnology Index Fund trade on various exchanges. For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit http://www.nasdaq.com.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, for the treatment of chronic HBV infection, is e
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
3. Pharmasset Accesses up to $30 Million of Working Capital
4. Pharmasset to Present at Three Investor Conferences in November 2007
5. Pharmasset Appoints Michael Rogers as Chief Development Officer
6. Pharmasset Reports Fiscal Year End 2007 Financial Results
7. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
8. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
9. Pharmasset to Present at Cowen & Companys Health Care Conference on Tuesday, March 18th
10. Pharmasset Appoints Herbert J. Conrad as a Director
11. Pharmasset Receives $10 Million of Working Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced ... quarter of fiscal year 2010 on December 10, 2009 at ... webcast to discuss the results at 11:30 a.m. EST on ... results for the second quarter ended October 31, 2009 and ...
(Date:12/2/2009)... is emerging as one of the fastest growing green energy ... Energy Group and True Green Planet,s President and Recycling Specialist ... over 25 years, stated that Spectrum Blue Steel is light ... spectacular earnings because of the bi products recovered by using ...
(Date:12/2/2009)... demonstration tires made with BioIsoprene technology, a ... the manufacture of synthetic rubber with renewable biomass, made ... will be on display at a lounge in the ... December 21, while the other tire will make appearances ...
(Date:12/2/2009)... 2 TechConnect World, an event bringing together ... in cleantech, nanotech, biotech and MEMS, announced the ... presentations. ,, Now in its 14th year, TechConnect ... Technology Institute (NSTI), and the Clean Technology and ...
Breaking Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3
... ... - Operating margin of 9.9% for the quarter,- Record backlog of over $2 ... ... today announced its financial results for the,fourth quarter and Fiscal Year ended June 30, 2008., For ...
... Partners announced today that,it has updated coverage and has ... INO ). "The proposed merger of Inovio and ... and deliver,therapeutic agents and positions Inovio/VGX, based on further ... other gene therapy,companies," said Ross Silver, Director of Research ...
... N.J., Aug. 6 Millennium,Biotechnologies, Inc., a wholly ... Board: MBTG) today named Mark C.,Mirken its new ... of,Directors., Mirken has been President and Chief ... in September of 2007. Mirken will replace Jerry,Swon ...
Other Biology Technology:PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 2PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 3PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 4PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 5PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 6PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 7PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 8PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 9PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 10PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 11PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 12PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 13PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results 14Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target 2Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc. 2Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc. 3
(Date:12/4/2009)... This release is available in German . ... Biology of Ageing could help to understand the positive effect ... organisms (fruit flies and mice) have shown that dietary restriction ... diminished fertility. So the female fruit fly reproduces less frequently ...
(Date:12/3/2009)... new information and adapt to changes in our daily environment, ... in the minute junctions where nerve cells communicate, according to ... study is published online this week in the journal ... PhD, associate professor of physiology and neuroscience at NYU School ...
(Date:12/3/2009)... believe that staph infections are caused by many bacterial cells ... is called quorum sensing because many bacteria must be present ... group has determined that the very first stage of staph ... form, occurs in a single cell and that this individual ...
Breaking Biology News(10 mins):How nutrition affects healthy aging 2Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 1NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 2NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 3Child Neurology Foundation Announces 2430 000 Grant for Research Into Cause and Treatment of Infantile Spasms 60236 1Child Neurology Foundation Announces 2430 000 Grant for Research Into Cause and Treatment of Infantile Spasms 60236 2Child Neurology Foundation Announces 2430 000 Grant for Research Into Cause and Treatment of Infantile Spasms 60236 3Health Partners to Offer Health Insurance Through the Childrens Health Insurance Program 60234 1Health Partners to Offer Health Insurance Through the Childrens Health Insurance Program 60234 2
... in Quartier Concordia along Ste. Catherine street or De ... see a demonstration of innovative Canadian technology conceived at ... of one facade of an institutional building - the ... world-first demonstration of this type of combined solar heat ...
... Congress of the International Osteoporosis Foundation and the European ... Osteoarthritis, to be held in Florence, Italy from May ... opportunity for clinicians and researchers from around the world ... field of osteoporosis and osteoarthritis. The,congress will offer an ...
... being forced to say no to a child crying for ... imagine it; that was normal life at her family,s dinner ... phenylketonuria (PKU), a genetic disease that means her body can,t ... described by scientists as an autosomal recessive genetic disease that ...
Other Biology News:A world-first in solar technology unveiled at Concordia University 2New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease 2New drug holds out promise of normal diet for sufferers of devastating PKU genetic disease 3